Results 61 to 70 of about 2,813 (193)

Oligoprogressive renal cell carcinoma: What is the role of surgery?

open access: yesBJU International, Volume 138, Issue 2, Page 219-228, August 2026.
Objective To provide an overview of the biological mechanism and pattern of oligoprogression in renal cell carcinoma (RCC) and the most updated role of surgery in this setting, highlighting scientific gaps and informing future implications. Methods A non‐systematic search of PubMed/MEDLINE was performed in August 2025 including guidelines, reviews, and
Chiara Re   +9 more
wiley   +1 more source

Role of Local Treatment for Oligometastasis: A Comparability Based Meta-Analysis

open access: yesCancer Research and Treatment, 2022
Purpose We intend to investigate the oncological efficacy and feasibility of local consolidative therapy (LCT) through a meta-analysis method.Materials and Methods Four databases including PubMed, MEDLINE, Embase, and Cochrane library were searched. Target studies are controlled trials comparing outcomes of LCT versus a control group. Primary endpoints
Rim, Chai Hong   +7 more
openaire   +3 more sources

A Case of Brachial Lymph Node Recurrences after the Resection of Locally Advanced Breast Cancer

open access: yesCase Reports in Oncology, 2022
We present a case of two recurrences in the brachial lymph nodes after initial resection, which was performed for radical cure. A 66-year-old woman was diagnosed with left breast cancer T4bN3cM0 Stage IIIC and an immunohistochemistry assay showed ...
Kayono Onishi   +5 more
doaj   +1 more source

Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma

open access: yes, 2021
Purpose: For bone metastasis from hepatocellular carcinoma (HCC), radiotherapy (RT) has been used a palliative treatment with little impact on survival. Currently, ablative RT is popularly used, and a more than palliative effect is expected.
최치환   +13 more
core   +1 more source

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang   +19 more
wiley   +1 more source

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy

open access: yesJournal of Hepatocellular Carcinoma, 2022
Kangpyo Kim, Joongyo Lee, Jinsil Seong Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of KoreaCorrespondence: Jinsil Seong, Department of Radiation Oncology, Yonsei University College of Medicine, 50-1 Yonsei-ro,
Kim K, Lee J, Seong J
doaj  

Visualized Clinical‐Radiomics Model Based on Non‐Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
NCCT radiomics for surufatinib efficacy prediction in HM‐NENs. ABSTRACT Background Hepatic metastatic neuroendocrine neoplasms (HM‐NENs) have few treatment biomarkers and low survival rates. We created a clinical‐radiomics fusion model based on non‐contrast computed tomography (NCCT) to predict Surufatinib efficacy in HM‐NENs.
Miaomiao Feng   +5 more
wiley   +1 more source

Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

open access: yesHepatology Research, Volume 56, Issue 5, Page 830-839, May 2026.
ABSTRACT Background Conversion therapy, which seeks to achieve curative treatment following systemic therapy, is increasingly acknowledged in the management of unresectable hepatocellular carcinoma (HCC). However, validated criteria for predicting eligibility for conversion remain unclear. We investigated the utility of the recently proposed borderline
Yasuto Takeuchi   +20 more
wiley   +1 more source

Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 4, April 2026.
Abstract Background and purpose MR‐Linac (MRL) is well‐suited for treatment of oligometastatic disease (OMD) in muscle due to its superior soft tissue contrast. The purpose of this study was to assess dosimetric differences and quantify margins when CT‐guidance (CTgRT) is used for OMD treatment compared to MR‐guidance (MRgRT) on the MRL.
Travis Salzillo   +15 more
wiley   +1 more source

Making Difficult Decisions in Lung Cancer: Oligometastasis, Ground Glass Opacities, Bilateral Lung Lesions, Surgery for Recurrence

open access: yes, 2018
Gilbert Massard of the Centre Hospitalier in Strasbourg, France, discusses difficult treatment decisions in lung cancer. He reviews the different treatment approaches for oligometastasis, ground glass opacities, and multiple primary lung cancers, and ...
Gilbert Massard (5451137)
core   +1 more source

Home - About - Disclaimer - Privacy